Drug Trial Radar · NCT01027429
Simplified Antibiotic Therapy for Sepsis in Young Infants
Last checked: Nov 20, 2026Latest source record: Jun 29, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,543
Actual
Start
Dec 2009
Primary completion
Dec 2013
Study completion Dec 2013
Sponsor
- Lead sponsor
- Aga Khan UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Save the Children; World Health Organization; London School of Hygiene and Tropical Medicine; Emory University
- First posted
- Dec 8, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, up to 59 days
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial evaluates primary care clinic-based simplified antibiotic therapy options for young infants, 0-59 days old in high neonatal mortality settings in peri-urban Karachi where hospital referral is frequently refused by families.
Conditions
- Neonatal Sepsis
- Sepsis
- Infection
Interventions
procaine penicillin and gentamicinDrug
procaine penicillin 50,000 units/kg by intramuscular injection once daily for 7 days; gentamicin, 5 mg/kg once daily by intramuscular injection for 7 days
amoxicillin and gentamicinDrug
oral amoxicillin 80-90 mg/kg divided in two doses for 7 days intramuscular gentamicin, 5 mg/kg once daily for 7 days
procaine penicillin, gentamicin, amoxicillinDrug
procaine penicillin, 50,000 IU/kg once daily intramuscular injection plus gentamicin 5 mg/kg once daily intramuscular injection for 2 days, followed by 5 days of oral amoxicillin, 80-90 mg/kg divided in two doses.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment failureTime frame: within 7 days of enrolment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ali Akber Shah Goth
Karachi, Sindh, Pakistan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.